Skip to main content
Log in
Home
All Courses
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I
Summary
Course
Credit Activity Report
PARS log
More
Course info
Conferences and Meetings
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I
Category:
Conferences and Meetings
Short name:
updated-322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I- 2023
Course start date:
01/11/2026
Enroll me
Sections
General
0 activities
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Poster I
0 activities
Proteomics Reveals the Potential Pathogenesis of Coagulopathy in Patients with Hematological Malignancies Following CAR-T Therapy
1 activities
Proteomics Reveals the Potential Pathogenesis of Coagulopathy in Patients with Hematological Malignancies Following CAR-T Therapy
Health Care Resource Use, Comorbidities, and Costs of Hemophilia A Patients in France: A Nationwide Claims Database Analysis
1 activities
Health Care Resource Use, Comorbidities, and Costs of Hemophilia A Patients in France: A Nationwide Claims Database Analysis
Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7
1 activities
Pharmacodynamic Biomarkers in Infants with Hemophilia A Receiving Emicizumab in HAVEN 7
Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry
1 activities
Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry
Predictors of Diagnostic Delays and Loss to Follow-up in Women with Von Willebrand Disease
1 activities
Predictors of Diagnostic Delays and Loss to Follow-up in Women with Von Willebrand Disease
Emicizumab Use in Infancy: A Survey of United States Pediatric Hemophilia Treatment Center Medical Directors
1 activities
Emicizumab Use in Infancy: A Survey of United States Pediatric Hemophilia Treatment Center Medical Directors
Assessment of ISTH-BAT Scores in a Primary Care Clinic Population of Menstruating Adolescents
1 activities
Assessment of ISTH-BAT Scores in a Primary Care Clinic Population of Menstruating Adolescents
Impact of Recombinant Factor VIII and Platelet Interaction on Platelet Functionality and Hemophilia a Treatment
1 activities
Impact of Recombinant Factor VIII and Platelet Interaction on Platelet Functionality and Hemophilia a Treatment
Heterotopic Ossification in Hemophilia: A Multi-Center Case Series
1 activities
Heterotopic Ossification in Hemophilia: A Multi-Center Case Series
Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause
1 activities
Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause
A Feasibility Study Evaluating Von Willebrand Factor in Patients with Gastrointestinal Angiodysplasia
1 activities
A Feasibility Study Evaluating Von Willebrand Factor in Patients with Gastrointestinal Angiodysplasia
Acute Cardiovascular Complications of Disseminated Intravascular Coagulation in Acute Myeloid Leukemia
1 activities
Acute Cardiovascular Complications of Disseminated Intravascular Coagulation in Acute Myeloid Leukemia
Fibrinolysis Assessment with Tpa-ROTEM in Patients with Bleeding Disorders of Unknown Cause (BDUC)
1 activities
Fibrinolysis Assessment with Tpa-ROTEM in Patients with Bleeding Disorders of Unknown Cause (BDUC)
Acquired Von Willebrand Syndrome, Epidemiology, Laboratory Findings and Molecular Alterations on Classic Myeloproliferative Neoplasms in Mexican Popul
1 activities
Acquired Von Willebrand Syndrome, Epidemiology, Laboratory Findings and Molecular Alterations on Classic Myeloproliferative Neoplasms in Mexican Popul
A Retrospective Analysis and Characterization of Female Patients with Bleeding Disorders Hemophilia B, Hemophilia B and Von Willebrands Disease and T
1 activities
A Retrospective Analysis and Characterization of Female Patients with Bleeding Disorders Hemophilia B, Hemophilia B and Von Willebrands Disease and T
Design of an Observational Study (PROVE) to Assess the Long-Term Effects of Prophylaxis with Simoctocog Alfa or Emicizumab on Joint and Bone Health in
1 activities
Design of an Observational Study (PROVE) to Assess the Long-Term Effects of Prophylaxis with Simoctocog Alfa or Emicizumab on Joint and Bone Health in
Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major
1 activities
Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major
Vimeo
17
Enroll me
Loading...
Help
Loading...
Accessibility
Text size
A-
A
A+
Color Adjustments
Monochrome
Low Saturation
High Saturation
High Contrast
Invert Colors
Change Hue
Reset Color Adjustments